🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary purpose of this study is to investigate the effect of Aprociten...
Status
Completed
Location
Cepha s.r.o
Start Date
2017-08-10
Trial ID
NCT03245229
Treatments Being Tested
The goal of this clinical trial is to learn if drug aprocitentan has an eff...
Status
Completed
Location
CEPHA s.r.o.
Start Date
2025-01-18
Trial ID
NCT06799884
Treatments Being Tested
The purpose of this research study is to show the blood pressure lowering e...
Status
Withdrawn
Location
Multiple Locations
Start Date
2020-01
Trial ID
NCT04162366
Treatments Being Tested
This clinical study will be conducted to evaluate the effect of ACT-132577 ...
Status
Completed
Location
Investigator Site Lausanne
Start Date
2016-06-01
Trial ID
NCT02708004
Treatments Being Tested
The objective of this study is to evaluate the tolerability, safety, and ph...
Status
Completed
Location
Anaheim Clinical Trials
Start Date
2018-07-17
Trial ID
NCT03586570
Treatments Being Tested
The main purpose is to study the pharmacokinetics of aprocitentan (ACT-1325...
Status
Completed
Location
CEPHA s.r.o.
Start Date
2022-02-02
Trial ID
NCT05196399
Treatments Being Tested
To demonstrate that multiple-dose administration of oral therapeutic and su...
Status
Completed
Location
CRS Clinical Research Services Mannheim GmbH
Start Date
2020-01-14
Trial ID
NCT04281342
The purpose of this study is to evaluate the effect of ACT-132577 on the ph...
Status
Completed
Location
Investigator Site
Start Date
2016-07-01
Trial ID
NCT02841761
Treatments Being Tested
The primary purpose of this study is to investigate the rate and routes (ur...
Status
Completed
Location
PRA Health Sciences
Start Date
2017-03-28
Trial ID
NCT03100591
Treatments Being Tested
The primary purpose of this study is to investigate the fate of ACT-132577 ...
Status
Completed
Location
CEPHA
Start Date
2017-06-03
Trial ID
NCT03165071
Treatments Being Tested